Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 434 record(s)

Req # A-2019-001545

Adverse Drug Reactions (ADRs). Report numbers: E2B_02358233, E2B_02408030, E2B_02420846, E2B_02421097, E2B_02403838, 000725864, 000726394, E2B_02534494, E2B_02502595, E2B_02520763, E2B_02667314, E2B_02521137, E2B_02634037, E2B_02528000, E2B_02532988, E2B_01984111, E2B_02573987, E2B_02613494, E2B_02613500, E2B_02614632, E2B_02708765.

Organization: Health Canada

455 page(s)
September 2023

Req # A-2020-000833

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-108579-651.

Organization: Health Canada

17 page(s)
September 2023

Req # A-2020-001274

Adverse Drug Reactions (ADRs). Report numbers: E2B_02656048, E2B_02656228, E2B_02656234, E2B_02656483, E2B_02657189, E2B_02657279, E2B_02658104, E2B_02658119, E2B_02658987, E2B_02659154, E2B_02659231, E2B_02659856, E2B_02660578, E2B_02660877, E2B_02661299, E2B_02661322, E2B_02661721, E2B_02661867, E2B_02662682, E2B_02662696.

Organization: Health Canada

389 page(s)
September 2023

Req # A-2021-000446

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-075596-362.

Organization: Health Canada

24 page(s)
September 2023

Req # A-2021-000663

Adverse Drug Reaction (ADR) for HYOSCINE BUTYLBROMIDE. Report number: E2B_03293753.

Organization: Health Canada

14 page(s)
September 2023

Req # A-2021-000912

Adverse Drug Reactions (ADRs) for Emend. Report numbers: E2B_01892612, E2B_02240071, E2B_02276242. ADRs for Gardasil 9. Report numbers: 000722186, E2B_02316724, E2B_02415017, 000713885, 000714715, 000716382, 000717497, E2B_02217606, E2B_02284818.

Organization: Health Canada

131 page(s)
September 2023

Req # A-2021-002104

Adverse Drug Reactions (ADRs) for PETHIDINE HYDROCHLORIDE, FLUDARABINE PHOSPHATE, ZOPICLONE. Report numbers: E2B_04931776, E2B_04810161, E2B_04661733, E2B_02464087, E2B_04674007, E2B_04819558, E2B_04821402, E2B_04825593, E2B_04819559, E2B_04819779, E2B_04819804, E2B_04836829, E2B_04622099, 976208.

Organization: Health Canada

375 page(s)
September 2023

Req # A-2022-000480

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-105261-759.

Organization: Health Canada

4 page(s)
September 2023

Req # A-2022-000600

Adverse Drug Reactions (ADRs). Report numbers: E2B_05218423, E2B_05234166, E2B_05293043, E2B_05302793, E2B_05168052, E2B_04998941, E2B_05206136, E2B_05118213, E2B_05239163, E2B_05249285.

Organization: Health Canada

99 page(s)
September 2023

Req # A-2022-001066

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-107475-990

Organization: Health Canada

93 page(s)
September 2023
Date modified: